‘Grand slam’ pill doubles survival rate for third deadliest cancer: study
There’s new hope for one of the world’s deadliest cancers. Groundbreaking clinical trial results show that an experimental new drug could double survival time for pancreatic cancer patients. Patients taking the daily pill lived, on average, about six months longer than those who received chemotherapy alone — and had fewer side effects. Pancreatic cancer is … Read more